Status:

UNKNOWN

Role of Multiplex PCR in CAP

Lead Sponsor:

Assiut University

Conditions:

Community-acquired Pneumonia

Eligibility:

All Genders

18-100 years

Brief Summary

1. role of multiplex PCR in early identifying bacteria in patients with lower respiratory tract infection. 2. effect of early starting targeted antibiotics on outcome

Detailed Description

Pneumonia remains a worldwide health problem with a high rate of morbidity and mortality. Identification of microbial pathogens which cause pneumonia is an important area for optimum clinical manageme...

Eligibility Criteria

Inclusion

  • male and female
  • Age \>18 years Old
  • Adult patients were included if they fulfilled:
  • radiographic and clinical criteria.
  • Radiographic findings included chest imaging with an airspace opacity, lobar consolida-tion, or interstitial opacities
  • new or worsening compared to available baseline. In addition, at least 2 of the following clinical criteria had to be fulfilled:
  • reported or documented fever \> 37.5
  • new worsening productive cough or increase in respiratory secretions in intubated patients
  • pleuritic chest pain 4) new/worsening dyspnea or hypoxia, defined as documented blood oxygen saturation \<92%.

Exclusion

  • Patients under 18 years old. Patients who refuse to participate in the study

Key Trial Info

Start Date :

November 1 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2024

Estimated Enrollment :

66 Patients enrolled

Trial Details

Trial ID

NCT06097117

Start Date

November 1 2023

End Date

December 1 2024

Last Update

October 24 2023

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.